Related Experiment Video
Updated: Jul 6, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
The multifunctional estrogen receptor-alpha F domain.
Debra F Skafar1, Changqing Zhao
1Department of Physiology, Wayne State University School of Medicine, 540 E. Canfield, Detroit, MI, 48201, USA. dskafar@med.wayne.edu
The estrogen receptor (ER) alpha F domain, a C-terminal region, influences receptor activity and tamoxifen response. Understanding ER F domain differences may enable selective control of nuclear hormone receptors.
Area of Science:
- Molecular Biology
- Endocrinology
- Genetics
Background:
- Nuclear receptors are transcriptional regulators with a multidomain structure (A-F).
- The estrogen receptor (ER) alpha F domain is a C-terminal region, relatively understudied.
- ER subtypes (alpha and beta) exhibit distinct activities.
Purpose of the Study:
- To review the role of the estrogen receptor (ER) alpha F domain.
- To highlight the F domain's contribution to ER subtype differences and tamoxifen activity.
- To explore therapeutic potential based on F domain variations.
Main Methods:
- Literature review focusing on the ER alpha F domain.
- Analysis of structural and functional data related to nuclear receptors.
- Comparison of ER alpha and ER beta F domain characteristics.
Main Results:
- The ER alpha F domain is crucial for tamoxifen's agonist activity.
- This domain modulates interactions with coregulators like steroid receptor coactivator-1.
- Differences exist between ER alpha and ER beta F domains.
Conclusions:
- The ER F domain plays a significant role in estrogen receptor function and drug response.
- Variations in F domains across nuclear receptors offer targets for selective modulation.
- Further research into F domain mechanisms could lead to novel therapeutic strategies.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
Intracellular Hormone Receptors
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Internal Receptors
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
